Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
Clinical trial NCT00003176 · COMPLETED
Trial details
- NCT number
- NCT00003176
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-03-25
- Primary completion
- 2001-12-03
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.